34 results on '"Samyshkin, Yevgeniy"'
Search Results
2. External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting
3. Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
4. Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios
5. Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
6. Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer
7. Health-systems efficiency in the Russian Federation: tuberculosis control
8. Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis
9. Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States
10. Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States
11. Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery/Reforme de la sante mentale dans la Federation de Russie : demarche integree favorisant l'integration sociale et le retablissement des malades/Reforma de la atencion de salud mental en la Federacion de Rusia: enfoque integrado para propiciar la insercion social y la recuperacion
12. 366 Feasibility study of a network meta-analysis and unanchored population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in patients with newly diagnosed advanced ovarian cancer
13. Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer
14. MM-138: Estimating the Number of US Patients with Multiple Myeloma (MM) at Different Lines of Treatment (LOT)
15. Mental Health Care Reforms in Europe: Rehabilitation and Social Inclusion of People With Mental Illness in Russia
16. Cost-Effectiveness of Stroke Unit Care Followed by Early Supported Discharge
17. PUL890549 Supplemetal Material - Supplemental material for Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
18. Supplemental material for High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
19. Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
20. Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension
21. High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
22. External validation of exacerbation and mortality outcomes of health economic decision models for COPD
23. An economic, financial and health systems analysis of systems to support mental health in the Sverdlovsk Oblast, Russian Federation
24. Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
25. Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis
26. Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
27. Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis
28. Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US
29. Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States
30. Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis
31. Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland.
32. Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis.
33. Rehabilitation and Social Inclusion of People With Mental Illness in Russia.
34. Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.